文献速递腹部泌尿生殖CT

体重指数对肾上腺腺瘤CT衰减的影响

Impact of body mass index on CT attenuation of adrenal adenoma.
PubMed 文献 · Eur J Radiol · 2018-10-02

本研究纳入36例经手术证实的肾上腺腺瘤患者,测量其平扫CT衰减值并评估透明细胞比例及体重指数等临床病理因素。结果显示,所有患者中CT衰减与透明细胞比例、体重指数及血皮质醇水平显著相关;在原发性醛固酮增多症或无功能腺瘤患者中,CT衰减与透明细胞比例或体重指数也显著相关。结论提示除病理因素外,包括体重指数和血皮质醇水平在内的脂代谢相关因素可影响肾上腺腺瘤的平扫CT衰减。

要点

  • 肾上腺腺瘤平扫CT衰减值不仅受病理透明细胞比例影响,还与体重指数和血皮质醇水平相关。
  • 在原发性醛固酮增多症或无功能腺瘤患者中,CT衰减与透明细胞比例或体重指数显著相关。
  • 阅片评估肾上腺腺瘤平扫CT衰减时,需考虑患者体重指数等脂代谢相关因素的潜在影响。

核心结论

  • 除病理因素外,包括体重指数和血皮质醇水平在内的脂代谢相关因素可影响肾上腺腺瘤的平扫CT衰减。

研究设计与样本

  • 研究纳入36例经手术证实的肾上腺腺瘤患者,其中原发性醛固酮增多症24例、库欣综合征8例、亚临床库欣综合征3例、无功能腺瘤1例;测量腺瘤及肝脏平扫CT衰减值,定性评估病理透明细胞比例,并获取肿瘤直径、体重指数、糖化血红蛋白、甘油三酯、总胆固醇、血皮质醇及血浆醛固酮水平等临床数据;采用简单线性回归和多元线性回归分析评估与CT衰减相关的影像及临床病理因素,分别对所有患者及25例原发性醛固酮增多症或无功能腺瘤患者进行分析。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate whether lipid metabolism-related factors regulate unenhanced CT attenuation in adrenal adenoma (AA).

MATERIALS AND METHODS: Thirty-six patients with surgically proven AAs were enrolled in this study. The patients' underlying diseases were the following: primary aldosteronism (n = 24), Cushing's syndrome (n = 8), subclinical Cushing's syndrome (n = 3) and non-functioning AA (n = 1). Unenhanced CT attenuation of AAs and liver was measured. Pathologically, clear cell ratio (CCR) constituting each AA was qualitatively assessed. Clinical data including tumor diameter, body mass index (BMI), hemoglobin A1c, triglyceride, total cholesterol, blood cortisol and plasma aldosterone levels were also obtained. Simple and multiple linear regression analyses were performed to evaluate the radiological and clinicopathological factors associated with CT attenuation of AAs for all patients and separately for 25 patients with primary aldosteronism or non-functioning AA.

RESULTS: For all patients, there was a significant correlation between CT attenuation and each of CCR, BMI and blood cortisol levels (p < 0.05). For patients with primary aldosteronism or non-functioning AA, there was also a significant correlation between CT attenuation and CCR or BMI (p < 0.05).

CONCLUSION: In addition to pathological factors, lipid-metabolism-related factors including BMI and blood cortisol levels can affect unenhanced CT attenuation of AA.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Nishie A, Asayama Y, Ishigami K, et al. Impact of body mass index on CT attenuation of adrenal adenoma. Eur J Radiol. 2018. PMID: 30396653. doi:10.1016/j.ejrad.2018.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。